Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats
Authors:
- Nagla A. El-ShitanyNENagla A. El-Shitany
- Sahar El-HaggarSESahar El-Haggar
- Karema El-DesokyKEKarema El-Desoky
- 1 July 2008
- journal article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 46 (7) , 2422-2428
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicityToxicology, 2006
- Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4Journal of Pharmacy and Pharmacology, 2004
- ALPHA-LIPOIC ACID AMELIORATES MYOCARDIAL TOXICITY INDUCED BY DOXORUBICINPharmacological Research, 2002
- The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in ratsPharmacological Research, 2001
- PROTECTIVE EFFECT OF THYMOQUINONE AGAINST DOXORUBICIN–INDUCED CARDIOTOXICITY IN RATS: A POSSIBLE MECHANISM OF PROTECTIONPharmacological Research, 2000
- Cardioprotection of rat heart myocytes with amifostine (Ethyol®) and its free thiol, WR-1065, in vitroEuropean Journal of Cancer, 1996
- Alpha Tocopherol Improves Focal Glomerulosclerosis in Rats with Adriamycin-lnduced Progressive Renal FailureNephron, 1994
- Comparative bioavailability of Silipide, a new flavanolignan complex, in ratsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1992
- Hyperlipidemic Effects of Adriamycin in RatsThe Japanese Journal of Pharmacology, 1985
- Anthracycline glycoside-membrane interactionsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1984